Related Experiment Video
Updated: Jun 28, 2026
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration
1Department of Ophthalmology and Vision Sciences, Keenan Research Centre at the Li Ka Shing, Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. yeni.yucel@utoronto.ca
Abstract:
The identification of mechanisms precipitating neuronal death and injury is an intense area of investigation requiring reliable models to assess the effects of neuroprotective agents. Most are suboptimal since the effects of initial damage are diffuse and may not be reproducible or easily quantifiable. The ideal laboratory model should have the ability to (a) clearly detect evidence of neuronal injury and recovery, (b) accurately measure morphologically the extent of these changes, and (c) provide functional evidence for damage and recovery. Glaucoma is a disease of visual neurons in the eye and brain. In the visual system, neuroanatomical pathways and retinotopic organization are exquisitely defined, functional modalities are highly characterized and can be dissected physiologically, visual input parameters can be modified, visual functional output can be readily tested and measured, changes in the eye and the visual brain can be directly visualized and imaged, and pathological and compensatory changes in brain centers of vision can be examined and measured specifically. For these reasons, the glaucoma disease model is ideal for the study of response and recovery to injury in the central nervous system due to anterograde and retrograde degeneration from the eye to the brain and the brain to the eye, respectively. The study of this glaucoma model of transsynaptic brain injury may be relevant to understanding more complex pathways and point to new strategies to prevent disease progression in other neurodegenerative diseases.
Insights
The glaucoma disease model offers a superior system for studying neuronal injury and recovery in the central nervous system. Its well-defined visual pathways allow for precise measurement of neurodegeneration and potential neuroprotective strategies.
Area of Science:
- Neuroscience
- Ophthalmology
- Neurodegeneration
Background:
- Identifying mechanisms of neuronal death requires reliable models for assessing neuroprotective agents.
- Current models often have diffuse, irreproducible, or difficult-to-quantify damage effects.
- An ideal model needs to detect, measure, and provide functional evidence of neuronal injury and recovery.
Purpose of the Study:
- To establish the glaucoma disease model as an ideal system for studying central nervous system injury and recovery.
- To leverage the visual system's defined pathways for precise analysis of neurodegeneration.
- To explore transsynaptic brain injury and its relevance to neurodegenerative diseases.
Main Methods:
- Utilizing the glaucoma disease model, which affects visual neurons in the eye and brain.
- Exploiting the visual system's defined neuroanatomical pathways and retinotopic organization.
- Employing physiological dissection, functional testing, and direct imaging to measure changes.
Main Results:
- The glaucoma model demonstrates anterograde and retrograde degeneration between the eye and brain.
- The visual system's characteristics enable specific examination and measurement of pathological and compensatory changes.
- This model allows for clear detection, morphological measurement, and functional assessment of neuronal injury and recovery.
Conclusions:
- The glaucoma disease model is exceptionally well-suited for studying central nervous system response and recovery to injury.
- This model provides a unique platform for investigating transsynaptic brain injury relevant to broader neurodegenerative conditions.
- Findings may inform new strategies for preventing disease progression in neurodegenerative diseases.
